Bleeding risk test for patients with low platelets
Part of Blood & lymphatic, Cancer clinical trials.
This study uses a special blood test to create a score that predicts bleeding risk in patients with blood cancers and very low platelet counts. It could help doctors decide if you need extra care to prevent bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a blood cancer (like leukemia or lymphoma) or bone marrow failure, at any stage of treatment.
- Your most recent blood test (within the last 3 days) showed a very low platelet count (less than 20 G/L), and you have not had a platelet transfusion since that test.
- You are being treated in a hematology clinic or hospital ward.
- You have not taken certain blood-thinning medications recently (antiplatelet drugs within 7 days, vitamin K antagonists within 7 days, direct oral anticoagulants within 3 days, low molecular weight heparin within 1 day, or unfractionated heparin within 6 hours).
- You are not taking a Bruton's tyrosine kinase inhibitor (like ibrutinib) within the last 3 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
This trial tests whether a one-time infusion of umbilical cord blood cells can safely raise platelet counts in people whose counts dropped after cancer treatment. It is for patients whose low platelets are clearly linked to their cancer therapy and who have no other major health problems.
This trial studies how best to prevent and treat dangerous blood clots in people with cancer who also have very low platelets. It may help guide safer blood-thinner treatment when bleeding risk is high.
This trial tests if a medication called etamsylate can help prevent bleeding in patients getting a stem cell transplant. If your platelet count drops very low after transplant, this drug may reduce your risk of bleeding.
This study looks at blood test antibodies to help confirm whether low platelet counts are caused by an autoimmune condition. It may help doctors better classify your type of low platelets and guide appropriate next steps.
This trial tests how a platelet transfusion affects blood vessel function in intensive care patients with low platelet counts (thrombocytopenia). It may help doctors understand if transfusions help the tiny blood vessels work better.
Hear when a new Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.